CIBC Private Wealth Group
VYGR icon

CIBC Private Wealth Group’s Voyager Therapeutics VYGR Stock Holding History

CIBC Private Wealth Group’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,000
Closed -$9.34K – 3541
2025
Q3 		$9.34K Buy
+2,000
New +$7.24K ﹤0.01% 2405
2018
Q2 		– Sell
-839
Closed -$16K – 2104
2018
Q1 		$16K Buy
+839
New +$18.1K ﹤0.01% 1432

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIBC Private Wealth Group's VYGR Position: Q4 2025 in Review

CIBC Private Wealth Group sold out of Voyager Therapeutics (VYGR) in Q4 2025, closing a stake of 2,000 shares — an estimated $9.34K sold.

CIBC Private Wealth Group first reported a position in VYGR in Q1 2018 and held it in 2 quarters. The position peaked at $16K in Q1 2018. 125 funds tracked by Wall St. Rank hold VYGR as of Q4 2025.

  • CIBC Private Wealth Group reported no remaining Voyager Therapeutics position as of Q4 2025 after selling out during the quarter.
  • CIBC Private Wealth Group sold 2,000 Voyager Therapeutics shares in Q4 2025, an estimated $9.34K.
  • CIBC Private Wealth Group first reported a position in Voyager Therapeutics in Q1 2018 and held it in 2 quarters.
  • CIBC Private Wealth Group's Voyager Therapeutics position peaked at $16K in Q1 2018.
  • 125 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.